Onyx HealthcareROCO:6569 75 Pretax Margin % is 16.57% as of Dec. 2025, which is 6% above its 10-year median of 15.56. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Onyx Healthcare ranks better than 69.43% on this metric.
The historical rank and industry rank for Onyx Healthcare's Pretax Margin % or its related term are showing as below:
ROCO:6569'
s Pretax Margin % Range Over the Past 10 Years
Min: 9.28 Med: 15.56 Max: 20.43
Current: 9.28
ROCO:6569's Pretax Margin % is ranked better than 69.43% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.015
vs ROCO:6569: 9.28
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Onyx Healthcare Pretax Margin % Related Terms
Onyx Healthcare Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Onyx Healthcare's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6569 vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, Onyx Healthcare's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Healthcare (ROCO:6569) has a Pretax Margin % of 16.57% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Onyx Healthcare and its competitors. This is near median its historical median of 15.56. Over the past decade, Onyx Healthcare's Pretax Margin % has ranged from 9.28 to 20.43. According to the industry distribution chart, Onyx Healthcare ranks #203 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 30.6%.
Is Onyx Healthcare's Pretax Margin % too high?
Onyx Healthcare's current Pretax Margin % of 16.57% is near median its 10-year median of 15.56. Over the past 10 years, this metric has ranged from a low of 9.28 to a high of 20.43. The Healthcare Providers & Services industry median Pretax Margin % is 4.02. Onyx Healthcare's value of 16.57% is 312.7% above this industry median. Based on the distribution chart, Onyx Healthcare ranks #203 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #203 out of 664 companies for Pretax Margin %. This puts Onyx Healthcare in the upper half of its industry. The industry median Pretax Margin % is 4.02. Onyx Healthcare's value of 16.57% is 312.7% above this benchmark. Historically, Onyx Healthcare's own Pretax Margin % has ranged from 9.28 to 20.43 over the past decade. While the company's 10-year median is 15.56 vs. the industry median of 4.02, Onyx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current Pretax Margin % of 16.57% is 312.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current Pretax Margin % is 16.57%, which is near median its own 10-year median of 15.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current Pretax Margin % is 16.57%, which is near median its 10-year median of 15.56 and 312.7% above the Healthcare Providers & Services industry median of 4.02. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Pretax Margin % is 16.57% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39.
GuruFocus considers Onyx Healthcare to be Modestly Undervalued.
Key valuation signals for ROCO:6569:
Pretax Margin %: 16.57% (near median its 10-year median of 15.56)
GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
Industry Position: 312.7% above the Healthcare Providers & Services median (#203 of 664)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score
Get the complete analysis for ROCO:6569
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
